acetylcysteine has been researched along with Demyelinating Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd ElWahed, MK; El Sharouny, SH; Elsayed, RM; Shaaban, MH; Tahef, AW | 1 |
| Millet, V; Moiola, CP; Pasquini, JM; Pasquini, LA; Soto, EF | 1 |
| Khan, M; Pannu, R; Singh, AK; Singh, I; Won, JS | 1 |
| Barbosa, E; Paintlia, AS; Paintlia, MK; Singh, AK; Singh, I | 1 |
4 other study(ies) available for acetylcysteine and Demyelinating Diseases
| Article | Year |
|---|---|
N-acetylcysteine protects against cuprizone-induced demyelination: histological and immunohistochemical study.
Topics: Acetylcysteine; Animals; Corpus Callosum; Cuprizone; Demyelinating Diseases; Myelin Sheath; Rats | 2022 |
Partial inhibition of proteasome activity enhances remyelination after cuprizone-induced demyelination.
Topics: Acetylcysteine; Animals; Corpus Callosum; Cuprizone; Cysteine Proteinase Inhibitors; Demyelinating Diseases; Disease Models, Animal; Gliosis; Male; Mice; Myelin Sheath; Nerve Fibers, Myelinated; Nerve Regeneration; Neurotoxins; NF-kappa B; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Treatment Outcome | 2009 |
A novel role of lactosylceramide in the regulation of lipopolysaccharide/interferon-gamma-mediated inducible nitric oxide synthase gene expression: implications for neuroinflammatory diseases.
Topics: Acetylcysteine; Animals; Antigens, CD; Antioxidants; Apoptosis; Astrocytes; Cells, Cultured; Demyelinating Diseases; Drug Evaluation, Preclinical; Enzyme Induction; Enzyme Inhibitors; Fatty Acids; Female; Gait Disorders, Neurologic; Galactosyltransferases; I-kappa B Proteins; Inflammation; Interferon-gamma; Lactosylceramides; Lipopolysaccharides; Morpholines; Nerve Tissue Proteins; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidation-Reduction; Phosphorylation; Proline; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Signal Transduction; Spinal Cord Injuries; Thiocarbamates; Transfection | 2004 |
N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Acetylcysteine; Age Factors; Analysis of Variance; Animals; Animals, Newborn; Antigens; CD11b Antigen; Cell Count; Cell Death; Cytokines; Demyelinating Diseases; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Female; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Infant, Newborn; Leukomalacia, Periventricular; Lipopolysaccharides; Male; Myelin Basic Protein; Nerve Degeneration; Neuroprotective Agents; O Antigens; Oligodendroglia; Pregnancy; Proteoglycans; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor alpha; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stem Cells; Survival Rate; Time Factors; Transcription Factors | 2004 |